§ BIOTECHNOLOGY
USD · BiotechnologyENTA
ENANTA PHARMACEUTICALS INC
USDSector · Biotechnology
§ 01 · PRICE
Price action
1D5D1M6MYTD1YMAX
§ 03 · SIGNAL STACK · WHAT THE INPUTS SAY
§ 05 · WHO OWNS IT
Top institutional holders
| Fund | Shares | % port | Δ Q/Q |
|---|---|---|---|
| JANUS HENDERSON GROUP PLC | 3.8M | 0.0% | n/a |
| JANUS HENDERSON GROUP PLC | 3.8M | 0.0% | +103% |
| Deep Track Capital, LP | 2.0M | 0.4% | ±0% |
| BlackRock, Inc. | 1.2M | 0.0% | +1% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | 0.0% | n/a |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | 0.0% | n/a |
◇ AC INTELLIGENCE
Top institutional owners for ENTA as of the most recent 13F reporting period (Q1 2026 · Period ended Mar 31). Δ Q/Q reflects share-count change vs. the prior filing — positive green means adding, negative red means trimming. Cross-reference with the ownership-mix bars below to see which strategy cohort is driving the flow.
§ 06 · WHO OWNS IT · BY STRATEGY
OTHER53.3% · 84 holders
QUALITY / COMPOUNDER27.7% · 7 holders
PASSIVE / INDEX15.0% · 7 holders
DEALER / BANK6.0% · 19 holders
TACTICAL / MACRO4.1% · 3 holders
SYSTEMATIC / QUANT3.2% · 6 holders
ACTIVIST0.2% · 1 holder
INCOME / DEFENSIVE0.2% · 5 holders
◇ AC INTELLIGENCE
Ownership mix by behavioral cohort. Top bars indicate which style of capital dominates the float — passive indexing, quality compounders, dealer/bank, systematic quant, etc. Big quality-compounder share means concentrated active conviction; heavy passive share means flows are dictated by index rebalances, not fundamentals.
§ 07 · INSIDER ACTIVITY · LAST 180 DAYS
NO INSIDER FILINGS
◇ AC INTELLIGENCE
No Form 4 filings on record for ENTA in the last 180 days.
§ 08 · COVERAGE · OUR RECENT NOTES
ENTA
ARTICLE3W
Treasury "Buybacks" Are Yield Curve Control—History Says It Won't Cap 10-Year Yields (Aug 23)
ENTA
ARTICLE4M
$430M Crude Short Lands 15 Minutes Before Trump's Iran Ceasefire. Fourth Time This Month. (Apr 23)
ENTA
ARTICLE5M